Schedule 13G ownership disclosure

BELLICUM PHARMACEUTICALS, INC

Security class unavailable · CUSIP: 079481404

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
430,078
Percent of class
5.1200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-016618
Form type
SC 13G
Filer
BELLICUM PHARMACEUTICALS, INC
CIK
CIK 1358403
Filed
Feb 09, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub